Gour Medical S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MLGML.PA research report →
About the company
Gour Medical SA specializes in creating and selling a variety of veterinary products designed for companion animals. Its portfolio notably includes cannabidiol (CBD) formulations for pets, which are marketed under the WEEDLEY brand. The company, headquartered in Paris, France, was established in 2014.
- CEO
- Serge Goldner
- IPO
- 2016
- HQ
- Paris, FR
Price Chart
- Market Cap
- $536.27K
- P/E
- 0.00
- P/S
- 81.98
- P/B
- 0.00
- EV/EBITDA
- 35.22
- Div Yield
- 0.00%
- Gross Margin
- -379.27%
- Op Margin
- -415.57%
- Net Margin
- 137.34%
- ROE
- -67.73%
- ROIC
- 321.27%
- Revenue
- $1.08 · -99.88%
- Net Income
- $-79,542.46 · 58.47%
- EPS
- $-0.02 · 58.51%
- Op Income
- $-56,145.8
- FCF YoY
- 0.00%
- 52W High
- $0.06
- 52W Low
- $0.02
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- -0.24
- Avg Volume
- 291
Get TickerSpark's AI analysis on MLGML.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MLGML.PA coverage
Recent articles, reports, and earnings notes.
No research on MLGML.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MLGML.PA report →Similar companies
Peers in the same neighborhood.